QUANTUM BLOCKCHAIN TECHNOLOGIES PLC Logo

QUANTUM BLOCKCHAIN TECHNOLOGIES PLC

QBT | IL

Overview

Corporate Details

ISIN(s):
GB00B50P5B53
LEI:
213800FC5DEC582CRZ89
Country:
United Kingdom
Address:
FIRST FLOOR, 1 CHANCERY LANE, WC2A 1LF LONDON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Quantum Blockchain Technologies PLC is a research and development (R&D) company focused on creating disruptive technologies for Bitcoin mining. The company's approach integrates advanced artificial intelligence, quantum computing principles, cryptography, and functional optimisation with novel hardware designs, including Field-Programmable Gate Arrays (FPGAs) and Application-Specific Integrated Circuits (ASICs). Since commencing its intensive R&D program in 2021, the company's primary objective has been to develop proprietary systems and methods that provide a significant competitive advantage and enhance efficiency and performance in the Bitcoin mining sector.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for QUANTUM BLOCKCHAIN TECHNOLOGIES PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-01 12:11
Related Party Transaction
Quantum Blockchain Technologies Plc - REPO Rollover
English 66.7 KB
2025-06-24 08:00
Related Party Transaction
Quantum Blockchain Technologies Plc - Final Results
English 1.0 MB
2025-06-19 10:50
Regulatory News Service
Quantum Blockchain Technologies Plc - Business Update
English 23.3 KB
2025-06-03 08:00
Environmental & Social Information
Quantum Blockchain Technologies Plc - AI Oracle Video & Bitcoin 2025
English 12.1 KB
2025-05-21 08:00
Board/Management Information
Quantum Blockchain Technologies Plc - Directorate Change
English 17.0 KB
2025-05-19 13:31
Board/Management Information
Quantum Blockchain Technologies Plc - Passing of a Non-Exec Director
English 10.3 KB
2025-01-24 10:21
Related Party Transaction
Quantum Blockchain Technologies Plc - Rollover of REPO
English 64.7 KB
2025-01-23 08:00
Share Issue/Capital Change
Quantum Blockchain Technologies Plc - Placing
English 12.3 KB
2025-01-17 08:00
Environmental & Social Information
Quantum Blockchain Technologies Plc - Bitcoin Mining - Method C Update
English 26.9 KB
2025-01-15 08:00
Regulatory News Service
Quantum Blockchain Technologies Plc - AI Oracle Patent Application
English 14.3 KB
2024-12-11 08:00
Remuneration Information
Quantum Blockchain Technologies Plc - Amendment and Grant of Share Options
English 115.7 KB
2024-10-24 08:00
Share Issue/Capital Change
Quantum Blockchain Technologies Plc - Method C Update
English 29.4 KB
2024-10-02 08:00
Director's Dealing
Quantum Blockchain Technologies Plc - REPO Rollover
English 63.0 KB
2024-09-23 11:06
Interim Report
Quantum Blockchain Technologies Plc - Correction: Interim Results
English 290.5 KB
2024-09-23 08:00
Earnings Release
Quantum Blockchain Technologies Plc - Interim Results
English 288.2 KB

Automate Your Workflow. Get a real-time feed of all QUANTUM BLOCKCHAIN TECHNOLOGIES PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for QUANTUM BLOCKCHAIN TECHNOLOGIES PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN